We are live on ! Find out more
MGPI icon

MGP Ingredients

121 hedge funds and large institutions have $775M invested in MGP Ingredients in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 40 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more call options, than puts

Call options by funds: $1.93M | Put options by funds: $551K

92.99% more ownership

Funds ownership: 0%92.99% (+93%)

44% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 16

34% more capital invested

Capital invested by funds: $580M → $775M (+$195M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

10% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 40

3% more funds holding

Funds holding: 117121 (+4)

Holders
121
Holders Change
+4
Holders Change %
+3.42%
% of All Funds
3.02%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
23
Increased
44
Reduced
40
Closed
16
Calls
$1.93M
Puts
$551K
Net Calls
+$1.38M
Net Calls Change
+$412K
Name Holding Trade Value Shares
Change
Change in
Stake
DIA
76
Denver Investment Advisors
Colorado
$598K +$531K +11,965 New
NFA
77
Nationwide Fund Advisors
Ohio
$584K -$33.6K -757 -6%
VFA
78
Virtus Fund Advisers
Connecticut
$556K +$134K +3,020 +37%
CS
79
Credit Suisse
Switzerland
$544K +$71.6K +1,613 +17%
FG
80
Formula Growth
Quebec, Canada
$500K
SFG
81
SNS Financial Group
Minnesota
$500K +$444K +10,000 New
VKH
82
Virtu KCG Holdings
New York
$463K +$411K +9,260 New
Manulife (Manufacturers Life Insurance)
83
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$429K -$7.86K -177 -2%
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
$419K +$13.6K +307 +4%
Citadel Advisors
85
Citadel Advisors
Florida
$393K +$349K +7,871 New
BCM
86
Bayesian Capital Management
New York
$381K +$339K +7,626 New
GCP
87
GSA Capital Partners
United Kingdom
$375K -$386K -8,700 -54%
SI
88
Scout Investments
Missouri
$365K -$234K -5,271 -42%
AIG
89
American International Group
New York
$361K -$843 -19 -0.3%
UBS Group
90
UBS Group
Switzerland
$344K -$21.4K -483 -7%
BA
91
BlackRock Advisors
Delaware
$334K +$9.72K +219 +3%
Stifel Financial
92
Stifel Financial
Missouri
$333K +$32.2K +725 +12%
NC
93
Northpointe Capital
Michigan
$311K -$5.64K -127 -2%
VOYA Investment Management
94
VOYA Investment Management
Georgia
$299K -$20.2K -454 -7%
Principal Financial Group
95
Principal Financial Group
Iowa
$265K +$235K +5,303 New
Truist Financial
96
Truist Financial
North Carolina
$261K +$232K +5,220 New
State Board of Administration of Florida Retirement System
97
State Board of Administration of Florida Retirement System
Florida
$252K
PPA
98
Parametric Portfolio Associates
Washington
$247K -$370K -8,343 -63%
Squarepoint
99
Squarepoint
New York
$241K +$214K +4,830 New
BG
100
BlackRock Group
United Kingdom
$231K +$31.7K +714 +18%

MGPI Hedge Fund Activity: Q4 2016 in Review

121 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in MGP Ingredients (MGPI) for Q4 2016, worth a combined $775M — up 34% from $580M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MGPI positions and 16 closed out — a net gain of 7 holders — while 44 added to existing stakes and 40 trimmed.

The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $27M. The largest seller was Pembroke Management, cutting an estimated $8.58M.

  • 121 institutional investors held MGP Ingredients (MGPI) as of Q4 2016, up from 117 in Q3 2016.
  • Funds reported $775M of MGP Ingredients stock for Q4 2016, up 34% quarter-over-quarter.
  • 23 funds opened new MGP Ingredients positions in Q4 2016 and 16 closed out, a net change of +7 holders.
  • The largest MGP Ingredients buyer in Q4 2016 was TimesSquare Capital Management, an estimated $27M added.
  • The largest MGP Ingredients seller in Q4 2016 was Pembroke Management, an estimated $8.58M sold.

Based on aggregated 13F filings for Q4 2016.